Summary
Down’s syndrome (DS) is a genetic disorder involving an excess of chromosome 21 (trisomy 21) in approximately 96% of the cases and comprises approximately 15% of the population with mental retardation (Heller, 1969). In addition to the constitutional mental deficiencies associated with the syndrome many DS patients develop dementia associated with Alzheimer’s disease (AD) in their later years of life (Thase et al., 1984). The genetic locus for Cu,Zn-superoxide dismutase (SOD1), a key enzyme in free radical metabolism, is located on chromosome 21, and the activity level of this enzyme is elevated by approximately 50% in a variety of cells of DS patients (see Kedziora and Bartosz, 1988; Sinet, 1982). Because alterations in free radical metabolism may be involved in neuronal death and may be associated with a number of pathological manifestations of DS, it is important to understand the role of free radical metabolism in cognitive impairments of DS, the topic discussed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ammeren, K., and Epstein, C. (1987) Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 21 fetal mice and human trisomy 21 fibroblasts. Pediatry. Res. 21: 88–92.
Brooksbank, B., and Balazs, R. (1984) Superoxide dismutase, glutathione peroxides and lipoperoxidation in Down’s syndrome fetal brain. Dev. Brain Res. 16: 37–44.
Brun, A. (1983) An overview of light and electron microscopic changes, in: Alzheimer’s Disease. The Stanford Reference. B. Reisberg, ed. HHHThe Free Press, A Division of MacMillan Inc., pp. 37–47.
Butters, N., Granholm, E., Salmon, D., and Grant, I. (1987) Episodic and semantic memory: a comparison of amnesic and demented patients. J. Chn. Exp. Neuropsychol. 5: 479–497.
Ceballos, I., Delabar, J., Nicole, A., Lynch, R., Hallewell, R., Kamoun, P., and Sinet, P. (1988) Expression of transfected human CuZn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochim biophys. Acta 949: 58–64.
Ceballos, I., Nicole, A., Briand, P., Grimber, G., Delacourte, A., et al. (1991a) Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome. Free Rad. Res. Comm. 12–13: 581–589.
Ceballos, I., Javoy-Agid, F., Delacourte, A., Defossez, A., et al. (1991b) Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer’s disease brains. Free Rad. Res. Conmi. 12–13: 571–580.
Clausen, J. (1984) Demential syndromes and the hpid metabohsm. Acta Neurol. Scand. 70: 345–355.
Delacourte, A., Defossez, A., Ceballos, I., Nicole, A., and Sinet, P. (1988) Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer’s disease. Neuroscience Lett. 92: 247–253.
Floyd, R., Zaleska, M., and Harmon, J. (1984) Possible involvement of iron and oxygen free radicals in aspects of aging in brain, in: Free Radicals in Human Biology, Aging and Disease. Armstrong, D., Sohal, R. and Slater, T., eds. HHHRaven Press, pp. 143–161.
Groner, Y., Elroy-Stein, O., Bernstein, Y., Dafni, N., Levanon, D., Danciger, E., and Neer, A. (1986) Molecular genetics of Down’s syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes. Cold Spring Harbor Symposia on Quant. Bio. 11: 381–393.
Harman, D. (1983) Free radical theory of aging: consequences of mitochondrial aging. Age 6: 86–94.
Halliwell, B. (1989) Oxidants and the central nervous system: some fundamental questions. Acta Neurol. Scand. 126: 23–33.
Heller, J. (1969) Human chromosome aberrations as related to physical and mental dysfunction. J. Hered. 60: 239–248.
Jaendel, C., Nicolas, M., Dubois, F., Nabet-Belleville, F., Penin, F., and Cuny, G. (1989) Lipid peroxidation and free radical scavengers in Alzheimer’s disease. Gerontology 35: 275–282.
Katzman, R., and Saitoh, T. (1991) Advances in Alzheimer’s disease. FASEB 5: 278–286.
Kedziora, J., and Bartosz, G. (1988) Down’s syndrome: a pathology involving the lack of balance of reactive oxygen species. Free. Rad. Bio. Med. 4: 317–330.
Mann, D. (1988) The pathological association between Down’s syndrome and Alzheimer’s disease. Mech. Ageing Dev. 43: 99–136.
Marklund, S., Adolfsson, R., Gottries, C. G., and Winblad, B. (1985) Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J. Neurol. Sci. 67: 319–325.
Martin, G. (1976) Genetics syndrome in man with potential relevance to the pathobiology of aging, in: Genetic Effects on Aging. Bergsma, P. and Harrison, D., Eds. Alan Liss Inc., NY, pp. 5–39.
Marx, J. (1991) Mutation identified as a possible cause of Alzheimer’s disease. Science 251 (4996): 876–877.
Misra, H., and Fridovich, I. (1976) Superoxide dismutase and the oxygen enhancement of radiation lethahty. Archs Biochem. Biophys. 176: 577–581.
Mizuno, Y., and Ohta, K. (1986) Regional distributions of thiobarbi turic acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J. Neurochem. 46(5): 1344–1352.
Percy, M., Dalton, A., Markovic, V., Crapper McLachlan, D., Hummel, J. Rusk, K., and Andrews, D. (1990) Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease. Amer. J. Med. Genetics 35: 459–467.
Perrin, R., Briancon, S., Jeandel, C., Artur, Y., Minn, A., Penin, F., and Siest, G. (1990) Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study. Gerontology 36: 306–313.
Petkau, A. (1978) Radiation protection by superoxide. Photobiology 28: 765–774.
Shah, S. (1979) Fatty acid composition of Hpids of human brain myehn and synaptosomes: changes in phenylketonuria and Down’s syndrome. Int. J. Biochem. 10: 477–482.
Sinet, P., Lejeune, J., and Jerome, H. (1979) Trisomy 21 (Down’s syndrome) glutathione peroxidase, hexose monophosphate shunt and I.Q. Life Sci. 24: 29–34.
Sinet, P. (1982) Metabolism of oxygen derivatives in Down’s syndrome. N.Y. Acad. Sci. 396: 83–94.
Southern, P., and Powis, G. (1988) Free radicals in medicine. I. Chemical nature and biological reactions. Mayo Clin. Proc. 63: 381–389.
Sulkava, R., Nordberg, U., Erkinjuntti, T., and Westermarck, T. (1986) Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer’s disease and other dementias. Acta Neurol. Scand. 73: 487–489
Subbarao, K., Richardson, S., and Ang, L. (1990) Autopsy samples of Alzheimer’s cortex show increased peroxidation in vitro. J. Neurochem. 55 (1): 342–345.
Thase, M., Tigner, R., Smeltzer, D., and Liss, L. (1984) Age-related neuropsychological deficits in Down’s syndrome. Biol. Psychiat. 19(4): 571–585.
Zemlan, F., Thienhaus, O., and Bosmann, H. (1989) Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation. Brain Res. 476: 160–162.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Brugge, K.L., Nichols, S., Delis, D., Saitoh, T., Truaner, D. (1992). The role of alterations in free radical metabolism in mediating cognitive impairments in Down’s syndrome. In: Emerit, I., Chance, B. (eds) Free Radicals and Aging. EXS, vol 62. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7460-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7460-1_19
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7462-5
Online ISBN: 978-3-0348-7460-1
eBook Packages: Springer Book Archive